Overview
All India Institute of Medical Science-New Delhi has invited open tender bids for "Purchase of Inj. Recombinant IGF-1" at New Delhi, Delhi — a Supply / Goods supply / goods on a Buy basis, carrying an estimated value of an estimated under ₹1 Cr (derived from the EMD, as the department didn't publish a value). Bids close on 16 July 2026. EMD is ₹50 K. Reference 11/H/Inj. Recombinant IGF-1/2026-27.
Timeline
Published
25 Jun 2026
Submission opens
25 Jun 2026
Submission closes
16 Jul 2026
Bid opening
17 Jul 2026
Tender documents
PDFTendernotice_1.pdfNIT · 520 KBZIPDownload all (zip)All 2 documents · 710 KB — one download
What’s insideBOQ_961257.xls 282 KB11HTED.pdf 650 KB
Documents are mirrored from the source portal for reference. Live bidding and authoritative documents remain on the official portal.
Complete tender details
Tender ID2026_AIMSD_914702_1
Reference No.11/H/Inj. Recombinant IGF-1/2026-27
OrganisationAll India Institute of Medical Science-New Delhi » Store DO - AIIMS New Delhi
Product categoryDrugs and Pharmaceutical Products
Estimated valueunder ₹1 Cr (est)
Form of contractBuy
EMD₹50,000
EMD exemptionAllowed
Tender feeNil
Payment modeOffline
Tender typeOpen Tender
CategorySupply / Goods
No. of covers2
Bid validity270 days
Two-stage biddingNo
Withdrawal allowedYes
LocationNew Delhi, Delhi
PIN110029
Bid opening placeMain Hospital Store, AIIMS New Delhi 110029
Inviting authoritySr. store officer on behalf of Director AIIMS
Frequently asked questions
What is this tender for?
All India Institute of Medical Science-New Delhi floated this tender for "Purchase of Inj. Recombinant IGF-1" — Supply / Goods work, procured as a supply / goods contract on a Buy basis.
What is the estimated value?
The value wasn't published; based on the EMD it works out to about under ₹1 Cr.
What are the EMD and tender fee?
EMD is ₹50 K; tender fee is nil.
When do bids close?
Bids close on 16 July 2026; bids open on 17 July 2026.